Paul B Manning - Net Worth and Insider Trading
Paul B Manning Net Worth
The estimated net worth of Paul B Manning is at least $714 Million dollars as of 2024-04-26. Paul B Manning is the Director, 10% Owner of Dova Pharmaceuticals Inc and owns about 14,762,242 shares of Dova Pharmaceuticals Inc (DOVA) stock worth over $414 Million. Paul B Manning is the Director, 10% Owner of Verrica Pharmaceuticals Inc and owns about 15,589,481 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $104 Million. Paul B Manning is also the Director of Liquidia Corp and owns about 5,965,784 shares of Liquidia Corp (LQDA) stock worth over $74 Million. Besides these, Paul B Manning also holds AveXis Inc (AVXS) , Taysha Gene Therapies Inc (TSHA) , Acumen Pharmaceuticals Inc (ABOS) , Candel Therapeutics Inc (CADL) . Details can be seen in Paul B Manning's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul B Manning has not made any transactions after 2023-12-14 and currently still holds the listed stock(s).
Transaction Summary of Paul B Manning
Paul B Manning Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul B Manning owns 8 companies in total, including Taysha Gene Therapies Inc (TSHA) , Verrica Pharmaceuticals Inc (VRCA) , and Dova Pharmaceuticals Inc (DOVA) among others .
Click here to see the complete history of Paul B Manning’s form 4 insider trades.
Insider Ownership Summary of Paul B Manning
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSHA | Taysha Gene Therapies Inc | 2023-11-17 | director & 10 percent owner |
VRCA | Verrica Pharmaceuticals Inc | 2023-07-24 | director & 10 percent owner |
DOVA | Dova Pharmaceuticals Inc | 2019-11-12 | director & 10 percent owner |
AVXS | AveXis Inc | 2018-05-15 | director & other: Former 10% Owner |
ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 10 percent owner |
LQDA | Liquidia Corp | 2023-12-14 | director & 10 percent owner |
CADL | Candel Therapeutics Inc | 2021-07-29 | director |
KTTA | Pasithea Therapeutics Corp | 2022-10-22 | 10 percent owner |
Paul B Manning Latest Holdings Summary
Paul B Manning currently owns a total of 7 stocks. Among these stocks, Paul B Manning owns 14,762,242 shares of Dova Pharmaceuticals Inc (DOVA) as of August 9, 2019, with a value of $414 Million and a weighting of 57.99%. Paul B Manning owns 15,589,481 shares of Verrica Pharmaceuticals Inc (VRCA) as of July 24, 2023, with a value of $104 Million and a weighting of 14.52%. Paul B Manning also owns 5,965,784 shares of Liquidia Corp (LQDA) as of December 14, 2023, with a value of $74 Million and a weighting of 10.34%. The other 4 stocks AveXis Inc (AVXS) , Taysha Gene Therapies Inc (TSHA) , Acumen Pharmaceuticals Inc (ABOS) , Candel Therapeutics Inc (CADL) have a combined weighting of 17.14% among all his current holdings.
Latest Holdings of Paul B Manning
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DOVA | Dova Pharmaceuticals Inc | 2019-08-09 | 14,762,242 | 28.04 | 413,933,266 |
VRCA | Verrica Pharmaceuticals Inc | 2023-07-24 | 15,589,481 | 6.65 | 103,670,049 |
LQDA | Liquidia Corp | 2023-12-14 | 5,965,784 | 12.37 | 73,796,748 |
AVXS | AveXis Inc | 2016-09-13 | 252,939 | 217.83 | 55,097,702 |
TSHA | Taysha Gene Therapies Inc | 2023-11-17 | 23,517,778 | 2.30 | 54,090,889 |
ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 4,010,678 | 3.19 | 12,794,063 |
CADL | Candel Therapeutics Inc | 2021-07-29 | 56,000 | 6.43 | 360,080 |
Holding Weightings of Paul B Manning
Paul B Manning Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul B Manning has made a total of 1 transactions in Dova Pharmaceuticals Inc (DOVA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Dova Pharmaceuticals Inc is the acquisition of 28,062 shares on August 9, 2019, which cost Paul B Manning around $445,344.
According to the SEC Form 4 filings, Paul B Manning has made a total of 8 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the acquisition of 200,000 shares on July 24, 2023, which cost Paul B Manning around $1 Million.
According to the SEC Form 4 filings, Paul B Manning has made a total of 3 transactions in Liquidia Corp (LQDA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Liquidia Corp is the acquisition of 279,330 shares on December 14, 2023, which cost Paul B Manning around $2 Million.
More details on Paul B Manning's insider transactions can be found in the Insider Trading History of Paul B Manning table.Insider Trading History of Paul B Manning
- 1
Paul B Manning Trading Performance
GuruFocus tracks the stock performance after each of Paul B Manning's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul B Manning is 4.42%. GuruFocus also compares Paul B Manning's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul B Manning within 3 months outperforms 11 times out of 32 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul B Manning's insider trading performs compared to the benchmark.
Performance of Paul B Manning
Average Return
-19.12%
Outperforming Transactions
38%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 8.71 | 4.42 | -3.54 | -19.12 | -25.67 | -9.23 |
Relative Return to S&P 500(%) | 7.14 | 0.77 | -7.86 | -26.73 | -33.16 | -21.43 |
Paul B Manning Ownership Network
Ownership Network List of Paul B Manning
Ownership Network Relation of Paul B Manning
Paul B Manning Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Paul B Manning is the director & 10 percent owner of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include Chief Financial Officer Kamran Alam , 10 percent owner Session R.a. Ii , and 10 percent owner Astellas Pharma Inc. .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Paul B Manning made 3 insider transaction in Taysha Gene Therapies Inc (TSHA) with a net purchase of 18,066,667. Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net sale of 549,095 shares made by Session R.a. Ii , a net purchase of 777,778 shares made by Stalfort John A Iii , and a net purchase of 444,444 shares made by Sean P. Nolan .
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 19,405,000 shares were bought by its insiders, resulting in a net purchase of 18,822,905 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Paul B Manning Mailing Address
Above is the net worth, insider trading, and ownership report for Paul B Manning. You might contact Paul B Manning via mailing address: 200 Garrett Street Suite S, Charlottesville Va 22902.